---
schema_version: "secwatch.filing_event.v1"
accession: "0000313616-23-000002"
form_type: "8-K"
ticker: "DHR"
cik: "0000313616"
company_name: "DANAHER CORP /DE/"
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T18:20:56.141891+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Danaher expects Q4 non-GAAP core revenue growth high-single digits, above prior guidance

## Summary
- Q4 estimated revenues up low-single-digit% YoY; non-GAAP core revenue growth high-single-digit% vs prior flat to low-single-digit decline guidance.
- Base business core revenue growth high-single-digit%, in line with previous guidance.
- Cepheid respiratory testing revenue exceeded $1B in Q4.
- Full Q4 and FY 2022 earnings call scheduled for Jan 24, 2023 at 8:00 a.m. ET.

## SEC filing metadata
- accession: 0000313616-23-000002
- form_type: 8-K
- ticker: DHR
- cik: 0000313616
- company_name: DANAHER CORP /DE/
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313616/000031361623000002/0000313616-23-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313616/000031361623000002/dhr-20230109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313616-23-000002
- JSON: https://secwatch.observer/filing/0000313616-23-000002.json
- Plain text: https://secwatch.observer/filing/0000313616-23-000002.txt

## Key facts
- Earnings Releases
  DANAHER CORP /DE/ reported fourth quarter 2022 results: revenue increase in the low-single digit percent range year-over-year. Guidance reaffirmed.
  - Period: fourth quarter 2022
  - Revenue: increase in the low-single digit percent range year-over-year
  - Guidance: reaffirmed
  - Result: preliminary results
  source text: For the fourth quarter 2022, estimated revenues are anticipated to increase in the low-single digit percent range year-over-year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/313616/000031361623000002/0000313616-23-000002-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
